Heartcore Enterprises, Inc. current report, 11 January 2023

Vollständiges Dokument

HeartCore Enterprises, Inc. — Form 8-K Summary

Business context and reporting period

The filing reports a material definitive agreement entered into on January 11, 2023, between HeartCore Enterprises, Inc. and kk.BloomZ, a Japanese corporation. HeartCore is headquartered in Tokyo and its common stock trades on the Nasdaq Capital Market under the symbol HTCR. The filing is not a periodic financial-results report.

Financial and commercial terms

  • HeartCore will provide BloomZ with consulting and services supporting a potential U.S. initial public offering, de-SPAC transaction, or other fundamental transaction.
  • The eight-month agreement provides cash compensation of $500,000: $200,000 on the effective date, $150,000 after three months, and $150,000 after six months.
  • Services performed after the term are compensated at $150 per hour.
  • BloomZ issued HeartCore a warrant, fully earned and vested on January 11, 2023, initially covering shares equal to 4% of BloomZ’s fully diluted share capital, subject to adjustment.
  • The warrant has an exercise price of $0.01 per share and may be exercised after BloomZ completes a qualifying U.S. IPO, SPAC transaction, or other fundamental transaction, through the tenth anniversary of that event.
  • The warrant includes a 9.99% equity blocker.
  • The filing does not provide HeartCore’s revenue, profit, cash flow, margins, debt, cash balance, liquidity, or valuation of the warrant.

Material changes, outlook, risks, and unusual items

  • The agreement creates a new contracted revenue opportunity and potential equity upside for HeartCore, but the filing does not state the accounting treatment, timing of revenue recognition, or fair value of the warrant.
  • BloomZ’s potential IPO, SPAC transaction, or other listing is not guaranteed. The warrant may have limited or no value if a qualifying transaction does not occur.
  • Either party may terminate the consulting agreement at any time upon notice, subject to its terms.
  • HeartCore’s services exclude legal advice, accounting services, investment-adviser or broker-dealer activities, securities-sale negotiations, investor discussions, transaction structuring, investor screening, due diligence, and investment valuation or financial-advisability advice.
  • The warrant’s number of shares will be adjusted at the IPO date to represent 4% of BloomZ’s fully diluted listed share capital, subject to the warrant’s adjustment provisions.

Important facts for investors to verify

  • Whether all scheduled cash payments were made and whether the agreement remained in effect through its intended eight-month term.
  • The accounting classification and reported value of the BloomZ warrant in HeartCore’s subsequent financial statements.
  • Whether BloomZ completed, or continues to pursue, a qualifying IPO, SPAC transaction, or other fundamental transaction.
  • The final number and class of shares underlying the warrant after any IPO-date adjustment and the practical impact of the 9.99% equity blocker.
  • Any subsequent disclosures regarding termination, additional post-term service fees, or material changes to the BloomZ relationship.